Abbvie M13-596 A Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients with Chronic Hepatitis C Virus Genotype 1 - 6 Infection (MAGELLAN-2)
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
AbbVie Inc.
Start Date
April 1, 2016
End Date
February 11, 2019
Administered By
Medicine, Gastroenterology
Awarded By
AbbVie Inc.
Start Date
April 1, 2016
End Date
February 11, 2019